drugset / Trial / NCT01157169
Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions
RandomizedCrossoverOpen-labelOther
Summary
The object of this study is to compare the rate and extent of absorption of an investigational formulation of buprenorphine 8 mg sublingual tablets manufactured by Barr Laboratories, Inc. to an equivalent oral dose of the commercially available reference product, Subutex® manufactured by Reckitt Benckiser, following and overnight fast of at least 10 hours.
Timeline
- Start
- 2007-08
- Primary completion
- 2007-09
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Buprenorphine | Other / unclassified | 8 mg | Other |
Indications
No indication recorded.